KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Total Debt (2018 - 2025)

Twist Bioscience (TWST) has disclosed Total Debt for 4 consecutive years, with $9.1 million as the latest value for Q4 2021.

  • On a quarterly basis, Total Debt rose 129.46% to $9.1 million in Q4 2021 year-over-year; TTM through Dec 2021 was $9.1 million, a 129.46% increase, with the full-year FY2021 number at $1.6 million, down 67.23% from a year prior.
  • Total Debt was $9.1 million for Q4 2021 at Twist Bioscience, up from $1.6 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $9.9 million in Q4 2018 to a low of $1.6 million in Q3 2021.
  • A 4-year average of $6.3 million and a median of $6.6 million in 2019 define the central range for Total Debt.
  • Biggest YoY gain for Total Debt was 129.46% in 2021; the steepest drop was 67.23% in 2021.
  • Twist Bioscience's Total Debt stood at $9.9 million in 2018, then dropped by 28.98% to $7.0 million in 2019, then plummeted by 43.47% to $4.0 million in 2020, then soared by 129.46% to $9.1 million in 2021.
  • Per Business Quant, the three most recent readings for TWST's Total Debt are $9.1 million (Q4 2021), $1.6 million (Q3 2021), and $2.4 million (Q2 2021).